Quarterly report pursuant to Section 13 or 15(d)

EQUITY Equity (Tables)

v3.22.2.2
EQUITY Equity (Tables)
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2022:
Cash Flow Hedge  Foreign Currency Items Total
(in thousands)
Balance at December 31, 2021 $ (8,558) $ (139,406) $ (147,964)
Other comprehensive income before reclassifications
50,178  (58,731) (8,553)
Amount reclassified from AOCI 2,634  —  2,634 
Net other comprehensive income 52,812  (58,731) (5,919)
Balance at September 30, 2022 $ 44,254  $ (198,137) $ (153,883)
Schedule of Weighted Average Number of Shares
The following table sets forth the computation of weighted average common shares outstanding:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022 2021 2022 2021
Weighted average common shares—basic 225,761,777  216,888,355  224,123,130  215,716,239 
Effect of dilutive securities:
    Stock options and restricted stock 6,060,991  6,912,045  7,409,515  — 
    Convertible senior notes 11,864,035  —  8,085,275  — 
Weighted average common shares—diluted 243,686,803  223,800,400  239,617,920  215,716,239 
Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022 2021 2022 2021
Options to purchase shares of common stock 3,750  3,750  3,750  7,727,064 
Restricted stock and deferred stock—unvested 1,340,319  91,275  1,260,701  3,207,115 
Conversion shares related to the convertible senior notes —  11,864,035  3,778,760  11,864,035 
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding 1,344,069  11,959,060  5,043,211  22,798,214